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It is now well established that tolerance of tissue homografts can be induced 
in  adult  mice  of  certain  strains  by performing a  parabiotic  union  between 
allogenic individuals  (I-14) or by the  intravenous  administration  of either  a 
single  dose  of  large  numbers  of  viable  spleen  cells  (7,  15)  or  by  repeated 
injections of spleen cells intravenously and intraperitoneal]y over a  prolonged 
period. 
The total number of cells injected and the length of time during which parabiosis 
had to be maintained to bring about a permanent state of immunological unresponsive- 
ness was found to be dependent on the genetic disparity between the donor and the 
host (16). Tolerance obtained by these methods may be transferred to isologous mice 
by injecting these animals at birth with a single intravenous injection of approximately 
5 million viable spleen cells derived from tolerant donors (17-19). More recently Brent 
and Gowland  (20-22)  confirmed  and extended our observations that  immunological 
tolerance of allogenic skin grafts could  be obtained in adult mice by repeated  injec- 
tions of a]logenic viable spleen cells. On the other hand, most examples of acquired 
immunological  tolerance of allogenie  tissue  grafts brought about either during  the 
immediate newborn period or later in adult life have involved the administration  of 
intact cells obtained from lymphoid tissues.  Linder  (23, 24),  however,  has  recently 
demonstrated  that tolerance of allogenic  skin  grafts can be achieved in  adult mice 
differing  at weak histocompafibility loci  by transplantation  of ovarian  tissue,  and 
Billingham  and Silvers  (25) reported a significant  prolongation of male skin survival 
in female mice of the C57B1 strain treated at early age by repeated injections of an 
antigenic extract prepared from lymphoid tissue of syngenic male mice. More recently 
Linder  (26) induced  tolerance of male skin isografts in  adult  (DBA  X  C57B1)F1 
female mice using a cell-free preparation taken from male donors.  Spleen, kidney, and 
liver taken from male mice were homogenized and after centrifugation the supernate 
was used after being previously subjected to freezing and thawing. Of 6 adult females 
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receiving 12 intraperitoneal injections of this material over a period of 3 to 4 months, 
5 became tolerant and accepted the corresponding male skin isografts permanently. 
In other donor-host systems such as C57B1  male to C57B1  female in which the re- 
cipient females were conditoned by 16 intraperitoneal injections of cell-free material 
taken from male donors, only 2 out of 8 animals showed acceptance of the male skin 
isografts. Also, Medawar  (27)  reported use of cell free preparations of homologous 
lymphoid tissues to prolong homograft survival in adult mice receiving a  single in- 
jection of the antigenic material combined with treatment by x-irradiation, amethop- 
terin, or homologous isoantibody. 
In this report studies will be presented demonstrating that specific immuno- 
logical tolerance of tissue homografts can be induced in mice of several strains 
by treating these animals either at birth or during adult life with a  series of 
injections  of  large  amounts  of  non-cellular  disrupted  material  prepared  by 
initial mechanical homogenization and then by repeated freezing and thawing. 
Upon repeated injections of this material both weak and strong histocompati- 
bllity barriers in the mouse have been overcome, permitting transplantation of 
male skin to female mice and allogenic tumor or skin to mice conditioned in this 
way. 
Material and Methods 
Mice of the C57B1/1,  C57B1/4,  C57B1/6,  C3H/Bi, A, DBA/2, and Balb/C strains as 
well as F1 hybrids resulting from the cross between C3H and A strain were used. 
Non-Viable Spleen Cell Preparat{on.--Adult mice (3 to 5 months of age) were used as spleen 
cell donors.  Animals were killed by an overdose of ether and after cleaning the skin with 
alcohol the spleens were removed, freed of the surrounding fat, and placed into a tightly fitted 
glass homogenizer containing 2 to 4 ml of lactate-Ringer's saline solution. Mter reducing the 
tissue to a homogeneous paste, the suspension was subjected to rapid freezing and thawing 
employing dry ice in absolute alcohol for freezing and warm (37°C) tap water for thawing. 
Four cycles of freezing and thawing were employed. Mter the last thawing the spleen suspen- 
sion was brought to a concentration of 1 spleen per ml and strained through 4 layers of surgical 
gauze. Mter this treatment the spleen suspension was checked under the microscope for the 
presence of intact cells following staining with trypan blue. In no instance could intact cells 
be detected in the spleen suspension prepared in this manner. Additional tests for presence of 
intact cells in the spleen suspensions consisted of ascertaining whether or not the injection  of 
large quantities of this material into susceptible recipients would elicit graft vs. host reactions. 
Several  trials of this kind, injecting spleen homogenates  derived from  A strain  mice into 
(A X  C57B1/1)F1 hybrids, failed to induce runt disease in the latter animals, demonstrating 
the absence in the spleen inocula of significant members of immunologically competent cells. 
Spleen Injection Schedule.-- 
(a)  Adult  mice: In most experiments,  recipient  mice received an initial intravenous  in- 
jection of 1 spleen equivalent  of the disrupted cell suspension into the tail vein. Prior to this 
treatment, mice received an intraperitoneal injection of heparin in dose of  50 U.S.P.  units  1 
per mouse. The single heparin treatment was found to be essential to prevent the occurrence 
of sudden death during or immediately  after intravenous administration of tissue homogenates. 
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Following the initial intravenous injection of spleen material, some experimental groups of 
mice were injected twice a  week with the same amount of  material by the intraperitoneal 
route. In other groups injections were performed also twice a week alternating the intravenous 
and the intraperitoneal routes. 
The total number of injections of spleen material varied with the donor-host  strain com- 
binations used, and in all experiments treatment was continued after test-grafting for periods 
of time ranging from 3 to 6 weeks. 
(b)  Newborn mice:  In all experiments using  newborn mice, animals were injected intra- 
peritoneally with the spleen suspension  according to the following schedule: during the 1st 
week of fife mice received 0.1 of a  spleen equivalent of the disrupted  cell suspension divided 
into 2 injections. One of these was given immediately after birth and  the other 3 days later. 
During the 2nd week the dose of spleen material was increased to 0.2 of a  spleen equivalent 
divided in 2 equal doses injected 3 days apart. During the 3rd  week mice were injected with 
0.4 of a  spleen equivalent also divided in 2 equal doses,  and  finally, during the 4th week mice 
were injected with 1 spleen equivalent of tissue divided in 2 equal doses.  Skin grafting to test 
for the tolerant state of treated mice was performed I week after weaning or when these animals 
were approximately 30 days of age. 
Skin Grafting.--Skin grafting was performed by the technique routinely used in this labora- 
tory (28) which essentially consists in placing a  piece of full thickness abdomiual skin taken 
from the donor onto a skin defect prepared in the back of the recipient. The graft was held in 
place with silk sutures. 
Evaluation of the success or failure of the skin graft was based on gross inspection. Grafts 
considered successful and reflecting full immunological tolerance showed no  signs of  inflam- 
mation, did not become hard, and grew hair luxuriantly. Rejection of grafts was characterized 
by an initial take followed by inflammation, induration, hardening of the graft, and ultimate 
complete slough. Prolonged survival of the graft was considered to be present when the graft 
showed a delayed onset of the early evidence of rejection. 
Tumor  Grafting.--The  tumor used in these studies was an adenocarcinoma arising spon- 
taneously in a  breeder mouse of the A strain. Grafting was performed by placing a  piece of 
healthy tumor into the subcutaneous tissue of the groin. This was done under fight ether 
anesthesia through a small incision of the skin which was closed with a single silk suture. 
Grafted mice were inspected 3 times a week for the appearance of new tumors in the site of 
implantation. Criteria of tumor "take" were appearance of a  distinct mass of at least 1 cm in 
diameter in the site of implantation, and progressive growth of the tumor leading to death of 
the recipient. 
RESULTS 
Male Skin Isografl Acceptance in Adult Female Mice of the C57B1/1, C57B1/4, 
and C57B1/6 Strains after Repeated Injections of Disrupted Male Spleen Cells.-- 
Eichwald and Silmser (29) demonstrated in certain strains of mice, particularly 
in those of the A and C57B1 strains, a histoincompafibility determined by the 
sex of the animal. In animals of these strains, whereas skin isografts performed 
from male to male, female to male, or female to female were always successful, 
those performed from male to female resulted in a rejection of the male graft 
with all the characteristics of an allogenic graft-rejection reaction. This phenom- 
enon was interpreted by Eichwald et al. (30), Hauschka (31), and Snell (32) as 
being due to the lack in the recipient female of the isoantigen dependent upon 
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ies from this and other laboratories support the concept that the Eichwald and 
Silmser phenomenon is of immunological nature since immunological tolerance 
of male  syngenic grafts  could be  achieved  in  females injected  at  birth  with 
male spleen cells (33, 34). Furthermore, studies from this laboratory using this 
system have demonstrated  that  tolerance  can be induced  in females even in 
adult life if male spleen  cells are administered  in  sufficient  large dosage in a 
single intravenous injection (7). 
In the present experiments  tolerance of male skin syngenic grafts has been 
produced in adult female mice of the C57B1/1, C57B1/4, and C57B1/6 strains 
subjected  to  repeated  injections  of  disrupted  spleen  cells  taken  from  male 
donors. 
In 1 group of experiments female mice of the C57B1/1 strain  2 to 3 months old were in- 
jected intravenously  with  1 spleen equivalent  of the disrupted  cell preparation.  Seven days 
later, injected mice were submitted to grafting of skin from male donors of the same strain. In 
another  group, similar female mice received an initial injection of 1 spleen equivalent of the 
disrupted spleen cell preparation by the intravenous route, and this was followed 3 days later 
by a series of intraperitoneal  injections of the same amount of antigenic preparation  given 3 
times per week. Mice of this 2nd group were skin grafted after the 3rd intraperitoneal  injection, 
and similar injections were continued for several additional weeks, the actual number being 
somewhat variable. Control groups of non-injected females of the C57BI/1 strain  were pre- 
pared by grafting them with skin derived from male donors. 
In another set of experiments adult C57B1/4 and C57B1/6 female mice received an initial 
intravenous injection of 1 spleen equivalent of the disrupted spleen cell preparation  followed 
3 days later by a series of intraperitoneal injections of the same amount of material. This treat- 
ment was then repeated 3 times a week for 2 weeks. In these 2 groups treated mice were skin- 
grafted after the 3rd intraperitoneal  injection.  Groups of non-treated  adult female mice of 
both of these C57B1 sublines were grafted with their corresponding male skin and served as 
controls. 
The results of these experiments are summarized in Table I. It  will be seen 
in  the  table  that  in  the  group of adult  female  mice  of the  C57B1/1  strain 
receiving  a  single  intravenous  injection  of  frozen-thawed  spleen  suspension 
taken from male donors, most of the animals rejected the  male skin graft as in 
the group of non-injected controls.  By contrast,  most of the females injected 
repeatedly with the disrupted spleen cell suspension accepted  and maintained 
the male skin graft up to the time this report  was written  (9 months).  For all 
practical purposes these grafts can be considered as  permanent,  and it can be 
postulated  that the  animals have been rendered  permanently  tolerant  of the 
male skin graft by this method of treatment.  Further,  the adult female mice of 
the C57B1 (sublines 4 and 6) prepared by repeated  injections of disrupted male 
spleen cells again showed a  high  incidence of prolonged survival of male skin 
grafts  and  were  most certainly  rendered  tolerant  during  adult  life  by  these 
manipulations. 
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Having  succeeded in  producing  what  appeared  to  be a  tolerant  state  with 
respect  to  syngenic  male-femaie  skin  transplantation  by  treatment  of  the 
females with disrupted male spleen cells during adult life, it seemed of interest 
to attempt to extend these observations to allogenic  transplantation  barriers. 
The initial efforts were designed to attempt to overcome the relatively weak 
non-H-2 barrier represented by the Baib/C and DBA/2 strain combination. 
Adult DBA/2 and Balb/C strain mice known to by syngenic at the H-2 histo- 
compatibility genetic locus  (H-2  d)  but  allogenic  with  respect to minor  and 
TABLE  I 
Male Skin lnograft Acceptance in Adult Female Mice of the C57B1 Strain (SubUnes 1, 4, and 6) 
Repeatedly  Injected with Disrupted Spleen Cells Derived from Male Donors 
No. of  No. of female mice  Host strain  Donor strain  injections*  accepting male skin grafts 
C57B1/1 females 
C57B1/4 females 
C57B1/6 females 
C57B1/1 males 
C57B1/4 males 
C57BI/6 males 
24§ 
None 
6§ 
None 
5§ 
None 
#er ~ 
1/lo  ~o 
14/16  87.5 
2/19  10.5 
6/7  85.7 
1/10  10 
7/8  87.5 
0/8  0 
* Each injection consisted in one spleen equivalent/mouse. 
Intravenously. 
§ First injection, intravenously. Subsequent injection intraperitoneally. 
weaker loci, were used. Mice of the DBA/2 were employed as recipients and 
mice of the Baib/C strain as donors. 
In 1 group of experiments DBA/2 mice (2 to 3 months of age) were injected with spleen 
cell preparations taken from Balb/C donors. The dosage of material employed was 0.5 spleen 
equivalents per injection. A  total of 13 injections was given alternating the intravenous and 
intraperitoneal routes. The interval between injections was 3  days.  After the  5th injection 
these animals were test-grafted with Balb/C skin, and the treatment continued for 8 additional 
injections. In another group DBA/2 strainmice of the same age were given a total of 9 injections 
of spleen material twice a week by the intraperitoneal route at the dose of 1 spleen equivalent 
per injection. In this instance treated mice were skin-grafted with the allogenic skin after the 
4th injection. A 3rd group of adult DBA/2 mice was given an initial intravenous injection of 
1 spleen equivalent followed by a  series of 7 intraperitoneal injections of the same amount of 
material twice a  week. Also, in this group mice were grafted with Balb/C skin immediately 
after the 4th injection. Finally, a 4th group of DBA/2 mice was treated according to the same 
schedule as was used in the preceding group, but in this instance the number of intraperitoneal 
injections following skin grafting was increased to 14. Thus, in the last group a  total of 18 
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The results of these experiments summarized in Table II demonstrate that all 
groups with the exception of that in which the administration of spleen material 
was performed solely by the intraperitoneal route showed a significant prolonga- 
tion of the survival time of the allogenic skin graft, as compared to the survival 
time observed in the group of non-treated controls. Furthermore, in the group 
receiving a total of 18 injections of the spleen material, 3 of 11 mice (27 per cent) 
maintained the Balb/C graft for at least 4 months. At this time each animal now 
apparently tolerant of the Balb/C skin was grafted with skin obtained from 
C3H donors which was rejected with a vigorous homograft-rejection reaction in 
TABLE II 
Induction  of Tolerance of Skin Homografts by Repeated Injections of Disrupted Spleen Calls in 
Adult Mice Syngenic at the H-2 Histocompatibility Locus 
Host strain 
DBA/2 
Donor strain 
Balb/C 
! 
No. of 
injections 
i 
!  13" 
95 
8§  i 
I  18§ 
i  None 
Dose per in- 
jection  spleen 
equivalents 
i/2 
1 
1 
1 
Skin graft acceptance 
2~er c¢~$ 
0/13  0 
0/9  0 
o/io  o 
3/11  27 
0/i2  0 
Median 
rejection 
time 
days 
26.3 
15.5 
30.0 
29.8 
14.6 
* Alternating intravenous and intraperitoneal injections twice a  week. 
:~ All injections intraperitoneally twice a week. 
§ First injection intravenously. Subsequent injections intraperitoneally. 
10 to 11 days. In no instance did the rejection of the third party allogenic skin 
affect the condition of the initial Balb/C graft toward which the tolerant state 
had been produced. 
It is to be concluded from these observations that a series of intravenous and 
intraperitoneal injections of material obtained from completely disrupted spleen 
cells can be used to produce both partial and complete tolerance of skin grafts 
across allogenic barriers in mice. In these  studies, to be sure, the barrier over- 
come was the somewhat weaker non-H-2 aUogenic barrier represented by the 
genetic disparity between the Balb/C and DBA/2 strains.  The specificity of 
the manipulation, however, was apparent since no takes or even prolongation 
of homograft survival was observed when transplants were made of skin from 
donors not employed in the original manipulation. 
Allogenic Skin and Tumor Graft Acceptance  across  Strong  1t-2  Histocompati- 
bility  Barriers.--It  next seemed pertinent to attempt with this technique to 
manipulate the strong H-2 histocompatibility barrier presented by the genetic 
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In these studies mice of the C3H, A, and F1 hybrids resulting from the cross between C3H 
females and A males were used. Mice of the C3H and A strain differ at the strong H-2 genetic 
locus (H-2  k and H-2 ~, respectively). In one group of experiments adult C3H mice (2 to 3 
months of age) received an initial intravenous  injection of frozen-thawed spleen  material 
derived from (C3H X  A)Ft hybrid donors followed by a series of intraperitoneal injections 
of the same amount of material given twice a week for 5~ weeks (11 injections). Immediately 
after the last injection in this series of mice, the animals were grafted with skin taken from 
(C3H X  A)F1 hybrid donors. Mter skin grafting, treatment was continued with disrupted 
spleen cells for an additional period of 3 weeks. Another group of C3H mice of this same age 
was injected twice a week for 8 weeks with disrupted spleen cell material derived from A strain 
donors, alternating the intravenous and intraperitoneal routes. In this instance animals were 
TABLE III 
Induction of Tolerance of Skin and  Tumor Homografls  in Mice Across  the H-2 Barrier 
Host strain 
C3H (adults) 
C3H (newborns) 
Donor strain 
(C3HXA)F1 
None 
A 
None 
A 
No. of 
injections 
18" 
22~ 
8§ 
Incidence of homograft acceptance 
Skin  Tumor 
per ce~ 
2/lo  20 
o/lo  o 
1/7  14 
o/ao  0 
4/7  S7 
per cenJ 
4/8  50 
0/8  0 
* First injection intravenously.  Subsequent injections intraperitoneally. 
Alternating intravenous and intraperitoneal injections, twice a week. 
§ First week, 10  million cells equivalent,  intraperitoneally,  2nd week, 20  million cells 
equivalent,  intmperitoneally,  3rd  week, 40 million cells equivalent,  intraperitoneally,  4th 
week, 80 million cells equivalent, intraperitoneally. 
grafted in some instances with skin and in other instances with tumor tissue derived from A 
strain donors. Following transplantation,  the disrupted spleen cell treatment was continued 
for an additional 4 weeks. Finally, a 3rd group of mice  of the C3H strain was injected intra- 
peritoneally with disrupted cell  material derived from A strain donors beginning at birth. The 
disrupted spleen cell treatment was given every subsequent week in increasing doses until the 
time of weaning as was described in the section of Material and Methods. All experimental 
groups had a corresponding set of non-treated  C3H controls grafted with skin from either 
(C3H X A)F1 hybrids or A skin or tumor. 
The results of  this series of experiments are  summarized in Table III. In 
this table it will be seen that a  few  C3H mice injected repeatedly with non- 
viable spleen material derived from either (C3H  X  A)  F1 hybrids or from A 
strain donors showed lasting tolerance and accepted the allogenlc skin grafts. 
For example, 2 of 10 (20 per cent) of C3H mice prepared by repeated injection 
during adult life of disrupted spleen cell preparation from (C3H X  A) F1 mice 
subsequently accepted skin grafts from (C3H X  A) F1 donors. Similarly, 1 of 750  IMMUNOLOGICAL  TOLERANCE 
7 of C3H mice prepared during adult life with disrupted cell preparations from 
A  strain  donors  became  tolerant  and  accepted  an  A  strain  skin  graft 
permanently. Fig.  1 illustrates the A strain skin growing with luxuriant white 
hair on the brown  C3H recipient made tolerant by the repeated injection of 
completely disrupted spleen cells. Further, 50 per cent of C3H mice pretreated 
during adult life with disrupted spleen cell preparation accepted allogenic grafts 
of a mammary adenocarcinoma which had developed spontaneously in A strain 
hosts. In these instances the allogenic tumor grafts not only showed successful 
take,  but  grew progressively and  metastasized ultimately causing  the  death 
of their tolerant allogenie recipients. 
Finally, as will be observed in the table, treatment with disrupted spleen cell 
material beginning immediately after birth induced tolerance of allogenic skin 
grafts in 57  per cent of treated  C3H mice.  By contrast,  in no instance  were 
allogenic grafts of A strain skin or tumor accepted in unconditioned C3H mice. 
Transfer  of Tolerance Induced  by Treatment with Disrupted Cells.--Previous 
studies  from this  laboratory have  demonstrated  that  tolerance for allogenic 
tissue  grafts induced  in  mice by the  intravenous  administration  at  birth  of 
viable  lymphoreticular  cells  can  be  transferred  to  syngenic  individuals  by 
injecting these animals during  the newborn period with lymphoreficular cells 
derived from tolerant donors  (17).  Similar transfer of tolerance was achieved 
in newborn mice when the cells injected were derived from individuals made 
tolerant during adult life (13). This transfer of tolerance has been attributed to 
transfer of viable lymphoreticular cells replicating in the tolerant recipient and 
reflecting  the  chimeric  state.  Since  repeated  injections  of  non-viable  spleen 
material  into  either  adult  or  neonatal  mice  appeared  from the  experiments 
reported herein to result in tolerance of allogenic tissue grafts, it was considered 
desirable to ascertain whether or not this state of non-reactivity could also be 
transferred  to  syngenic  mice  by  injecting  the  latter  animals  at  birth  with 
viable lymphoreticular  cells  derived  from mice previously made  tolerant  by 
injection of disrupted spleen cells. 
In 1 group of experiments neonatal female mice of the C57B1/1 strain were made tolerant 
of syngenic male skin grafts by a single intravenous injection of approximately 5 million viable 
spleen cells derived from male donors or by the repeated administration of disrupted non- 
viable male spleen  cells following  the regular procedure described in this report. Approximately 
3 months after test skin grafting, tolerant females from each of these groups were sacrificed, 
the spleens were removed and made into a cell suspension containing 6 to I0 million viable 
cells in 0.1 ml of lactate-Ringer's saline solution. These suspensions were then injected intra- 
venously into groups of newborn female mice of the same strain. When these in~ected mice 
were approximately 2 months of age they were grafted with skin grafts taken from syngenic 
male donors, and the incidence of tolerance obtained in each group was determined. Groups 
of non-injected controls were also prepared and similarly grafted with male skin. 
The  results  of  these  experiments  are  shown  in  Table  IV.  These  results 
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birth of viable male spleen cells were able to transfer their tolerance to syngenic 
newborn female recipients.  Indeed,  such transfer resulted in tolerance of all 
female animals tested (8 of 8). By contrast, when tolerance of the male skin had 
been produced during adult  life by injection of disrupted  male  spleen  cells 
tolerance could not  be  transferred.  Further,  DBA/2  mice made  tolerant at 
birth by the injection of viable spleen cells obtained from Balb/C donors were 
capable of transferring this tolerance to syngenic newborn mice by means of 
their spleen cells in 16 of 19 instances (85 per cent). Again in striking contrast, 
DBA/2 mice made tolerant during adult life by repeated injections of disrupted 
TABLE IV 
Attempt to Transfer Tolerance Induced by Disrupted Cells 
Host strain  Donor strain cells  Incidence of skin  graft acceptance 
C57B1/1 females (newborns) 
DBA/2 
C57B1/1 females tolerant of male* 
C57B1/1 females tolerant of male:~ 
None 
DBA/2 tolerant of Balb/C* 
DBA/2 tolerant of Balb/C§ 
None 
per Cent 
8/8  100 
0/6t  0 
2/19  10.5 
16/19][  84 
0/6[1  0 
0/12  0 
* Tolerance induced by intact cells at birth. 
:~ Grafted with skin from male donors of the same strain. 
§ Tolerance induced by disrupted cells during adult life. 
[1 Grafted with skin from Balb/C  donors. 
spleen cells obtained from Balb/C mice were unable to transfer tolerance da 
their intact spleen cells to syngenic newborn recipients in any instance. 
These  observations  indicate  clearly  that  whatever  its  basis,  the  specific 
immunologic negativity induced with  intact  cells in  neonatal animals  or in 
adult life is transferable to newborn syngenic recipients, while that induced 
during adult life with disrupted spleen cells cannot be transferred in this way. 
DISCUSSION 
The results of these experiments are of interest for a number of reasons. In the first 
place it is shown that in newborn as well as adult mice a tolerant state may be pro- 
duced by repeated injections of large amounts of material derived from completely 
disrupted spleen cells. In this regard our observations confirm and extend those of 
Linder (25), and Billingham  and Silvers  (25). Billingham  and Silvers found that a 
significant prolongation of male skin graft survival may be obtained in C57B1 mice 
treated  in  the  neonatal period by repeated injections of material prepared from 
lymphoid  tissue  of  male  donors.  Linder  (26) showed  that  adult  females  of  the 
(DBA X C57B1)F1 strain may be made tolerant of male skin by repeated injections of 752  IMMUNOLOGICAL  TOLERANCE 
disrupted  male  spleen  cells.  In  our  experiments  the  histocompatibility  barrier  de- 
pendent on the Y chromosome in mice of the C57B1 strain (sublines 1, 4, and 6) was 
overcome regularly by injecting female mice during adult life with extracts of spleen 
tissue from syngenic male mice. The preparation of spleen tissue involved mechanical 
disruption and repeated freezing and thawing. In the experiments where the greatest 
tolerance-providing  effect was obtained the injection  of disrupted  cell preparations 
was given by the intravenous route, both prior to and following transplantation of skin. 
Similar manipulations of recipient adult  mice served regularly to prolong homograft 
survival in  strains  of mice differing at non-H-2  genetic loci as in  the  Balb/C  and 
DBA/2 strains. In these strain combinations these manipulations regularly permitted 
prolonged survival of grafts and in some instances permanent survival of allogenic 
skin grafts.  Even the histocompatibility barrier  conditioned  by the  1-1-2 histocom- 
patibility locus represented by (C3H ×  A)F1 into C3H or A into C3H could be bridged 
by injections  of the  disrupted  spleen  cell preparations  in  the  neonatal period  and 
during adult life. When the tissue transplanted was tumor rather than skin the trans- 
plantation  barrier  was  more  readily  overcome  by this form of conditioning. Thus, 
the conditioning provided by repeated intravenous and intraperitoneal injections of 
preparations of complete disrupted spleen cells regularly led (a)  to prolonged homo- 
graft  acceptance  across all genetic  barriers studied;  (b)  regular acceptance  of male 
skin  by female mice  in  several  C57B1  subline  strains;  (c)  frequent  acceptance  of 
skin homografts across the weaker non-H-2  histocompatibillty barriers;  (d)  regular 
acceptance of tumor homografts across the strong  (H-2) genetic barrier; and  (e) oc- 
casional  acceptance  of skin  homografts  across  the  strong  (H-2)  histocompatibility 
barrier. Further, long-lasting tolerance was quite regularly produced even across the 
strong H-2 genetic barrier by repeated intravenous and intraperitonea|  injections of 
disrupted spleen cell preparations given in the neonatal period. Evidence is presented 
indicating that like the several other forms of immunological negativity the tolerant 
state produced  during adult life by repeated injection  of disrupted  allogenic spleen 
cells is specific.  In these experiments, for example, DBA/2 strain mice made tolerant 
of Balb/C skin by injection of disrupted Balb/C spleen cells were fully capable of re- 
jecting allogenic skin grafts derived from a 3rd party strain (C3H). 
The dose of material employed and the route of administration also were important 
in  production  of  tolerance with  disrupted  spleen  cell preparations.  A  single intra- 
venous injection of one spleen equivalent of disrupted spleen cells in the C57B1  male- 
female combination did not induce tolerance of male skin, whereas 4 injections of the 
same amount of material given prior to grafting together with a  series of injections 
provided following grafting yielded a high incidence of tolerance. Further, the studies 
employing DBA/2 mice injected with disrupted spleen cells from Balb/C donors indi- 
cated that at least 1 injection by the intravenous route is essential to production of a 
tolerant state with this material. When treatment was provided by the intraperitoneal 
route  alone,  complete tolerance was never observed and  strikingly  the  survival  of 
the allogenic skin was not even prolonged. The age of the recipient also appeared to 
play a role. When injection of disrupted spleen cells from A strain mice were made into 
C3H recipients the younger animals developed a  higher incidence of complete toler- 
ance than was the case when the recipient mice were older. This observation is in keep- 
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mysterious about the relative ease of production of tolerant states in embryonic or 
neonatal life, but rather  that this facility is a  reflection of the relative cellular de- 
ficiencies of the lymphoreticular tissues during the early stages of development. 
Comparison of efforts to transfer tolerance to syngenic  newborn mice from mice 
made  tolerant  with  viable spleen  cells and  with  disrupted  spleen  cell preparations 
supports our previous contention that long-lasting tolerance produced by injection of 
viable spleen cells is associated with persistence and replication of cells from the original 
donor (10,  13, 17-19). The mice made tolerant either as adults or as neonates  by in- 
jection of the disrupted spleen cell preparations revealed no capacity to transfer the 
tolerant state to syngenic newborn recipients. 
Another point worthy of discussion in regard to these observations is the  finding 
that the tolerant state induced  either in neonatal or adult  mice by injection of the 
disrupted  spleen cell preparations appears to be very long-lasting and  may be con- 
sidered  permanent  for  all  practical  purposes.  Skin  grafts  from  male  to female  in 
C57B1/1 strain have remained in place more than 9 months, and allogenic skin grafts 
to animals conditioned with disrupted spleen cells have remained in place more than 5 
months without signs of deterioration or sloughing. These observations would suggest 
either that the antigens responsible for the tolerant state are only very slowly metabo- 
lized, like the pneumococcal polysaccharide in Felton's  experiments (36-39), or that 
the  skin graft itself is able to maintain  the  tolerant  state once tolerance has been 
established by injection of the disrupted cell preparation. 
The observations presented in this paper we consider to provide support for our 
contention  repeatedly  formulated  that  immunologic  tolerance  of allogenic  skin  or 
organ grafts is not a  unique phenomenon  but is essentially a  function of the  same 
central  immunologic failure responsible for immunologic paralysis,  protein  antigen 
over-loading (40, 41), oral ingestion of haptenic materials (42), and immunological un- 
responsiveness of soluble protein antigens presented in the neonatal period  (43-45). 
All of these phenomena represent a state of specific immunologic negativity, the basic 
mechanism of which has not yet been elucidated and continues to demand analysis. 
The observations, reported herein, that tolerance produced with completely disrupted 
spleen cells cannot be transferred might be taken as a rather telling argument against 
Gorman's (46) hypothesis that tolerant states represent positive cellular proliferation 
of immunologically incompetent  clones  of cells which possess receptors  capable of 
competing with those of the immunologicaUy competent clones for antigen. 
The  implications  of  these  observations  on  approaches  to tissue  and organ 
transplantation  in  higher  animals  including  man  are  meaningful.  Certainly 
direct application of these findings to facilitate organ transplantation  in man is 
not  possible.  First  of all,  the  dosage of disrupted  cell material needed  is pro- 
hibitive  in  any  system  where  virtually  unlimited  resources  of  syngenic 
lymphoid tissue are not available. However, it is most encouraging to note that 
a  tolerant  state can be produced  with cell-free preparations  during adult  life. 
The relative ease of accomplishment of a  tolerant state in strain combinations 
where  the  histocompatibility  barriers  are  relatively weak  portends  favorable 
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Further,  in  none  of  these  studies  have  efforts been  made  to  reduce  those 
lymphoreficular  resources  of  the  host  capable  of  positive  immunological 
response.  Such  manipulation could materially reduce  the  antigenic require- 
ments and diminish the demand for prohibitively large donor contributions. 
Study of the antigenic resources of the donor has in this report been limited 
to spleen cells, and studies currently in process may reveal additional resources 
in  the  potential  donor  that  will  narrow  the  gap  between  requirement  and 
resources available. Finally, encouragement to pursue this direction of investiga- 
tion is to be derived from observations Of Dresser (47) and Battisto and Miller 
(48)  that the condition of the antigen, and the route of exhibition of antigen 
may play  a  crucial  role  in  determining  whether  tolerance  or  immunity is 
produced with even small amounts of antigenic material. 
SUMIMARY 
I. Tolerance of male skin  isografts  has been regularly  produced in female 
mice of the C57BI strain  sublines  I, 4, and 6 during  adult  life  by repeated 
injection of completely disrupted spleen cells  derived from male donors. The 
tolerant state is long-lasting since such grafts have remained in place more 
than 9 months. 
2.  Prolonged survival of homotransplants of skin has regularly been produced 
in DBA/2 mice during adult life by repeated injections of completely disrupted 
spleen  cells  from Balb/C  donors.  When  injections  of  disrupted  spleen  cell 
material are continued over a  sufficiently long period, permanent acceptance 
of the skin homografts may be obtained between these strains. 
3.  Immunological tolerance across even  the strong H-2  histocompatibility 
barrier was obtained in the neonatal period and during adult life by repeated 
injection of disrupted spleen  cell preparations.  The  tolerant state has been 
revealed by both mammary adenocarcinoma and skin homografting across this 
strong histocompatibility barrier. 
4.  In contradistinction to the tolerant state produced by injection of intact 
spleen cells in neonatal animals or during adult life or that produced by para- 
biotic union, the tolerance produced by repeated injection of disrupted spleen 
cell preparations cannot be transferred to syngenic neonatal mice with spleen 
cells of the tolerant animal. 
5.  The  implications  of  these  findings  in  transplantation  biology and  in 
consideration of the basic nature of tolerance are discussed. 
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EXPLANATION OF PLATE 80 
FIG. 1. Tolerance of allogenic skin grafts induced by repeated injections of disrupted 
spleen cells. Mouse at right is of the DBA/2 strain made tolerant of Balb/C and mouse 
at left is of the  C3H strain made tolerant of A  strain.  Picture was taken approxi- 
mately 3 months after grafting.  X  1. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 118  PLATE  80 
(Martinez et al.: Immunological tolerance) 